**Summary Report: Earnings Conference Call Q2 2021**

**Introduction:**
John Faucher, Chief Investor Relations Officer, provided an update on the company's performance for the second quarter and the outlook for 2021. The discussion highlighted challenges such as COVID-19 impacts, raw material costs, and competitive activity, alongside strategies to drive long-term growth and shareholder returns.

**Key Financial Metrics - Q2 2021:**
- **Organic Sales Growth:** Achieved a 5% increase, marking the 10th consecutive quarter within or above the targeted range of 3% to 5%. Growth observed both in developed (3%) and emerging markets (7%).
- **Net Sales:** Increased by 9.5%, the highest in nearly a decade, with foreign exchange contributing a 4.5% benefit.
- **Gross Margin:** Gross profit margin at 60%, down by 80 basis points YOY, primarily due to increased raw material costs.
- **Operating Profit:** Grew by 5.5% on a GAAP basis and 2.5% on a base business basis.
- **Earnings Per Share (EPS):** Increased by 12% on a GAAP basis and 8% on a base business basis.
- **Free Cash Flow:** Decreased YOY, attributed to strong working capital performance in the previous year.

**Performance by Division:**
- **North America:** Net sales declined by 4%, with organic sales down 4.5%. Oral care grew mid-single digits, driven by innovation and pricing.
- **Latin America:** Net sales up 12.5%, with 8.5% organic growth. High teens growth in oral care. Brazil and Mexico showed strong growth.
- **Europe:** Net sales grew 15%, with organic sales up by 5%, led by growth in Oral Care.
- **Asia Pacific:** Reported 7.5% net sales growth and 1% organic growth. Growth in India and Thailand offset declines in China.

**Strategic Initiatives:**
- **Innovation:** Continued focus on product innovation such as Co by Colgate and Colgate Elixir toothpaste to drive growth and premiumization.
- **Revenue Growth Management:** Leveraging pricing strategies to offset rising raw material costs and to manage inflationary pressures.
- **Productivity:** Emphasis on improving productivity across operations to boost gross margin performance.

**Guidance for 2021:**
- **Sales:** Organic sales growth expected to remain within the 3% to 5% target range. Net sales projection adjusted to an increase of 4% to 7%.
- **Gross Margin:** Anticipated to be down YOY, with a sequential improvement expected in H2 2021.
- **Advertising and Logistics Costs:** Expected to increase, impacting SG&A but moderated by ongoing productivity measures.
- **Tax Rate:** Expected to be between 23% and 24% for the year.
- **Earnings:** EPS growth projected in the low-to-mid single digits on a GAAP basis and mid-to-high single digits on a base business basis.

**Conclusion:**
Despite unprecedented challenges, including raw material cost inflation and political disruptions, the company remains committed to driving profitable growth through strategic innovation, efficient pricing management, and enhanced productivity. The focus is on balancing volume and pricing growth across all categories and regions, while also progressing with sustainability initiatives to support community and environmental wellbeing.

**Investment Stance: Overweight**
Based on the consistent performance in organic sales growth, strategic initiatives to manage costs, and promising growth in emerging markets, the recommended investment stance is 'Overweight'. This reflects confidence in the company's ability to navigate current challenges and capitalize on growth opportunities, providing attractive returns to shareholders.